Laboratory Forecast, price target & analysts
Laboratory Target price 2025 - Analyst rating & recommendation
Laboratory Classifications & Recommendation:
Laboratory Price Target
| Target Price | $274.18 |
| Price | $248.76 |
| Potential |
10.22%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Laboratory 2026 .
The average Laboratory target price is $274.18.
This is
10.22%
register free of charge
$300.00
20.60%
register free of charge
$248.00
0.31%
register free of charge
|
|
| A rating was issued by 23 analysts: 19 Analysts recommend Laboratory to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratory stock has an average upside potential 2026 of
10.22%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 13.01 | 13.91 |
| 6.97% | 6.89% | |
| EBITDA Margin | 15.67% | 17.12% |
| 11.77% | 9.29% | |
| Net Margin | 5.69% | 7.37% |
| 73.25% | 29.42% |
17 Analysts have issued a sales forecast Laboratory 2025 . The average Laboratory sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Laboratory EBITDA forecast 2025. The average Laboratory EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Laboratory Analysts have issued a net profit forecast 2025. The average Laboratory net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 8.84 | 12.23 |
| 85.32% | 38.35% | |
| P/E | 20.34 | |
| EV/Sales | 1.94 |
7 Analysts have issued a Laboratory forecast for earnings per share. The average Laboratory EPS is
This results in the following potential growth metrics and future valuations:
Current Laboratory Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
| Redburn Atlantic |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 10 2025 |
|
Locked
Redburn Atlantic:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 04 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
